Oregon Clinical and Translational Research Institute Quality Assurance and Quality Control Project

俄勒冈临床和转化研究所质量保证和质量控制项目

• 批准号: 10158949
• 负责人: David H Ellison
• 金额: $ 14.93万
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-09-02 至 2022-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10158949
• 关键词: Address; Administrative Personnel; Attention; Attitude; Award; Biomedical Research; Budgets; Businesses; Clinical; Clinical Research; Clinical Sciences; Clinical Trials; Collaborations; Communities; Complex; Disease; Effectiveness; Evaluation; Event; Fostering; Funding Opportunities; Future; Goals; Health Sciences; Home environment; Human Resources; Informatics; Institutes; Institution; Investments; Knowledge; Lead; Leadership; Learning; Location; Maintenance; Measures; Monitor; Oregon; Outcome Measure; Patient Recruitments; Periodicity; Persons; Positioning Attribute; Principal Investigator; Process; Quality Control; Reporting; Research; Research Institute; Research Personnel; Research Support; Resources; Science; Services; Structure; Support System; System; Testing; Trainers Training; Training; Translational Research; Universities; clinical care; cost; improved; innovation; next generation; programs; quality assurance; skills; success; tool; translational scientist

The Oregon Clinical and Translational Research Institute (OCTRI) has been accelerating research at Oregon Health & Science University since 2006. Its many highly functional programs assist investigators and trainees by providing diverse services. Here, we propose that OCTRI will transition to retain our strengths, but also become a key hub in the national network, by focusing on five crosscutting aims. These align closely with the goals of the Funding Opportunity Announcement, and the goals outlined by NCATS for the CTSA program in an ideal state. OCTRI's overall aims are to: Overall Aim 1: Catalyze Clinical and Translational Research. Overall Aim 2: Enhance Partnerships with Communities. Overall Aim 3: Foster and Support Scientific Collaboration. Overall Aim 4: Expand the Translational Workforce for the 21st Century. Overall Aim 5: Cultivate Innovation in Research. We have organized a highly functional leadership structure to enable us to meet these goals, and will seek the guidance of several advisory groups. We will catalyze research by developing and supporting new informatics approaches that both integrate the clinical care enterprise with the research enterprise and facilitate the recruitment of patients into clinical trials, locally and across the CTSA network. We will engage diverse stakeholders in the translational research process, by partnering with OHSU investigators, community coalitions, and business enterprises. We will foster team science through local awards to trainees and to emerging investigators. We will partner with regional institutions to foster community-engaged research, to enhance the diversity of trainees, and to provide opportunities in biomedical research not available at other institutions. We will train clinical and translational scientists and research staff for the next generation, by focusing on the skills and attitudes necessary for research in the future. At all steps, we will measure outcomes and, when necessary, “turn the curve.”

俄勒冈州临床和转化研究所 (OCTRI) 一直在加速俄勒冈州的研究 健康与科学大学自 2006 年成立。其许多功能强大的项目为研究人员和学员提供帮助 在这里，我们建议 OCTRI 进行转型，以保留我们的优势，但也 通过重点关注与国家网络密切相关的五个交叉目标，成为国家网络的关键枢纽。 资助机会公告的目标，以及 NCATS 为 CTSA 计划概述的目标 OCTRI 的总体目标是： 总体目标 1：促进临床和转化研究。 总体目标 2：加强与社区的伙伴关系。 总体目标 3：促进和支持科学合作。 总体目标 4：扩大 21 世纪的翻译队伍。 总体目标 5：培养研究创新。 我们组织了一个功能强大的领导结构，使我们能够实现这些目标，并将寻求 我们将通过开发和支持新的信息学来促进研究。 将临床护理企业与研究企业相结合并促进 我们将在本地和整个 CTSA 网络中招募患者参加临床试验。 转化研究过程中的利益相关者，通过与 OHSU 研究人员、社区合作 我们将通过向受训者和企业颁发本地奖项来促进团队科学。 我们将与地区机构合作，促进社区参与的研究，以 增强学员的多样性，并提供其他机构无法提供的生物医学研究机会 我们将为下一代培养临床和转化科学家和研究人员。 关注未来研究所需的技能和态度 在所有步骤中，我们都会衡量结果。 并在必要时“扭转局面”。